Market Cap 4.16B
Revenue (ttm) 1.52B
Net Income (ttm) 128.49M
EPS (ttm) N/A
PE Ratio 20.33
Forward PE 18.83
Profit Margin 8.48%
Debt to Equity Ratio 0.46
Volume 933,700
Avg Vol 775,572
Day's Range N/A - N/A
Shares Out 59.43M
Stochastic %K 29%
Beta 0.62
Analysts Strong Sell
Price Target $102.00

Company Profile

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery sy...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 801 253 1600
Fax: 801 253 1652
Address:
1600 West Merit Parkway, South Jordan, United States
ZacksResearch
ZacksResearch Mar. 12 at 5:09 PM
$MMSI catching a strong tailwind — but there’s a catch. Merit Medical is riding solid cardiovascular demand and fast-growing therapeutic devices, a combo fueling the bullish case. But tariffs, OEM weakness, and China macro pressures are real clouds investors shouldn’t ignore. ⚠️ See the full bull/bear breakdown here 👉 https://www.zacks.com/stock/news/2883254/heres-why-you-should-add-merit-medical-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2883254-teaser-37202&ADID=SYND_STOCKTWITS_TWEET_2_2883254_TEASER_37202
0 · Reply
ZacksResearch
ZacksResearch Mar. 12 at 4:09 PM
$MMSI down 18.1% in six months — is a rebound on the horizon? 📉 Merit Medical is banking on its cardiovascular devices, projecting 5-7% revenue growth for 2026, driven by rising cardiovascular procedure volumes globally, despite tariff and China-related pressures. 🚀 Opportunity assessment here 👉 https://www.zacks.com/stock/news/2883254/heres-why-you-should-add-merit-medical-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2883254-body-37203&ADID=SYND_STOCKTWITS_TWEET_2_2883254_BODY_37203
0 · Reply
ZacksResearch
ZacksResearch Feb. 25 at 7:56 PM
$MMSI beats expectations — what drove the surge? 🚀 Merit Medical posted a Q4 EPS of $1.04, topping the Zacks Consensus Estimate by 8.3%, with revenue growth in most areas except for OEM. U.S. and EMEA regions showed impressive gains, and both margins expanded, boosting investor confidence. Discover the full earnings breakdown here 👉 https://www.zacks.com/stock/news/2875413/merit-medical-q4-earnings-revenues-beat-estimate-margins-expand?cid=sm-stocktwits-2-2875413-body-35200&ADID=SYND_STOCKTWITS_TWEET_2_2875413_BODY_35200
0 · Reply
ZacksResearch
ZacksResearch Feb. 25 at 6:56 PM
$MMSI quietly delivered the kind of quarter bulls love. 💪 Q4 EPS climbed 12%, earnings and revenues beat estimates, and margins expanded — powered by strong Cardiovascular growth and solid U.S. and EMEA sales. That’s operating leverage showing up where it counts. Momentum building here? Full breakdown 👉 https://www.zacks.com/stock/news/2875413/merit-medical-q4-earnings-revenues-beat-estimate-margins-expand?cid=sm-stocktwits-2-2875413-teaser-35199&ADID=SYND_STOCKTWITS_TWEET_2_2875413_TEASER_35199
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 24 at 9:23 PM
$MMSI Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.64 up 33.33% YoY • Reported revenue of $393.94M up 10.92% YoY • Merit Medical Systems, Inc. anticipates total revenue for fiscal year 2026 to be $1.61B to $1.63B, representing 6%-8% year-over-year growth on a reported basis, and Non-GAAP EPS of $4.01 to $4.15, up 5%8%.
0 · Reply
Estimize
Estimize Feb. 24 at 4:00 PM
$MMSI reports after the close, Estimize Consensus +0.03 EPS and +5.23M Revs compared to WS http://www.estimize.com/mmsi/fq4-2025?utm_conten
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 23 at 9:24 PM
0 · Reply
BillyHouse264
BillyHouse264 Feb. 21 at 6:21 AM
$MMSI Merit Medical Systems supplies medical devices. Growth depends on procedure volumes. Margins benefit from innovation.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 19 at 11:30 AM
$MMSI Current Stock Price: $82.93 Contracts to trade: $85.0 MMSI Feb 20 2026 Call Entry: $0.84 Exit: $1.37 ROI: 64% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 18 at 8:27 PM
$MMSI RSI: 56.20, MACD: -0.7999 Vol: 1.28, MA20: 81.40, MA50: 84.36 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Latest News on MMSI
Merit Medical Has To Rebuild Some Confidence In The Growth Story

Sep 9, 2025, 12:18 AM EDT - 6 months ago

Merit Medical Has To Rebuild Some Confidence In The Growth Story


The Market Is Vulnerable. 6 ‘Defensive' Stocks to Buy Now.

Jun 9, 2025, 12:46 PM EDT - 9 months ago

The Market Is Vulnerable. 6 ‘Defensive' Stocks to Buy Now.

CRM EXC MSI


Merit Medical Acquires Biolife Delaware, L.L.C.

May 20, 2025, 7:30 AM EDT - 10 months ago

Merit Medical Acquires Biolife Delaware, L.L.C.


Merit Medical Systems, Inc. (MMSI) Q1 2025 Earnings Call Transcript

Apr 25, 2025, 12:05 AM EDT - 11 months ago

Merit Medical Systems, Inc. (MMSI) Q1 2025 Earnings Call Transcript


Merit Medical Launches the Ventrax™ Delivery System

Apr 9, 2025, 9:25 AM EDT - 1 year ago

Merit Medical Launches the Ventrax™ Delivery System


Merit Medical: A Success Story That Keeps Getting Better

Mar 16, 2025, 12:34 PM EDT - 1 year ago

Merit Medical: A Success Story That Keeps Getting Better


First Patient Enrolled in Merit Medical's PREEMIE Study

Mar 10, 2025, 9:25 AM EDT - 1 year ago

First Patient Enrolled in Merit Medical's PREEMIE Study


Merit Medical Launches basixSKY™ Inflation Device

May 21, 2024, 9:25 AM EDT - 1 year ago

Merit Medical Launches basixSKY™ Inflation Device


ZacksResearch
ZacksResearch Mar. 12 at 5:09 PM
$MMSI catching a strong tailwind — but there’s a catch. Merit Medical is riding solid cardiovascular demand and fast-growing therapeutic devices, a combo fueling the bullish case. But tariffs, OEM weakness, and China macro pressures are real clouds investors shouldn’t ignore. ⚠️ See the full bull/bear breakdown here 👉 https://www.zacks.com/stock/news/2883254/heres-why-you-should-add-merit-medical-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2883254-teaser-37202&ADID=SYND_STOCKTWITS_TWEET_2_2883254_TEASER_37202
0 · Reply
ZacksResearch
ZacksResearch Mar. 12 at 4:09 PM
$MMSI down 18.1% in six months — is a rebound on the horizon? 📉 Merit Medical is banking on its cardiovascular devices, projecting 5-7% revenue growth for 2026, driven by rising cardiovascular procedure volumes globally, despite tariff and China-related pressures. 🚀 Opportunity assessment here 👉 https://www.zacks.com/stock/news/2883254/heres-why-you-should-add-merit-medical-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2883254-body-37203&ADID=SYND_STOCKTWITS_TWEET_2_2883254_BODY_37203
0 · Reply
ZacksResearch
ZacksResearch Feb. 25 at 7:56 PM
$MMSI beats expectations — what drove the surge? 🚀 Merit Medical posted a Q4 EPS of $1.04, topping the Zacks Consensus Estimate by 8.3%, with revenue growth in most areas except for OEM. U.S. and EMEA regions showed impressive gains, and both margins expanded, boosting investor confidence. Discover the full earnings breakdown here 👉 https://www.zacks.com/stock/news/2875413/merit-medical-q4-earnings-revenues-beat-estimate-margins-expand?cid=sm-stocktwits-2-2875413-body-35200&ADID=SYND_STOCKTWITS_TWEET_2_2875413_BODY_35200
0 · Reply
ZacksResearch
ZacksResearch Feb. 25 at 6:56 PM
$MMSI quietly delivered the kind of quarter bulls love. 💪 Q4 EPS climbed 12%, earnings and revenues beat estimates, and margins expanded — powered by strong Cardiovascular growth and solid U.S. and EMEA sales. That’s operating leverage showing up where it counts. Momentum building here? Full breakdown 👉 https://www.zacks.com/stock/news/2875413/merit-medical-q4-earnings-revenues-beat-estimate-margins-expand?cid=sm-stocktwits-2-2875413-teaser-35199&ADID=SYND_STOCKTWITS_TWEET_2_2875413_TEASER_35199
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 24 at 9:23 PM
$MMSI Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.64 up 33.33% YoY • Reported revenue of $393.94M up 10.92% YoY • Merit Medical Systems, Inc. anticipates total revenue for fiscal year 2026 to be $1.61B to $1.63B, representing 6%-8% year-over-year growth on a reported basis, and Non-GAAP EPS of $4.01 to $4.15, up 5%8%.
0 · Reply
Estimize
Estimize Feb. 24 at 4:00 PM
$MMSI reports after the close, Estimize Consensus +0.03 EPS and +5.23M Revs compared to WS http://www.estimize.com/mmsi/fq4-2025?utm_conten
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 23 at 9:24 PM
0 · Reply
BillyHouse264
BillyHouse264 Feb. 21 at 6:21 AM
$MMSI Merit Medical Systems supplies medical devices. Growth depends on procedure volumes. Margins benefit from innovation.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 19 at 11:30 AM
$MMSI Current Stock Price: $82.93 Contracts to trade: $85.0 MMSI Feb 20 2026 Call Entry: $0.84 Exit: $1.37 ROI: 64% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 18 at 8:27 PM
$MMSI RSI: 56.20, MACD: -0.7999 Vol: 1.28, MA20: 81.40, MA50: 84.36 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 12 at 1:07 AM
$MMSI Share Price: $81.28 Contract Selected: Jul 17, 2026 $85 Calls Buy Zone: $9.35 – $11.55 Target Zone: $15.00 – $18.34 Potential Upside: 52% ROI Time to Expiration: 155 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 2 at 6:47 PM
$MMSI Share Price: $81.18 Contract Selected: Jul 17, 2026 $85 Calls Buy Zone: $9.35 – $11.55 Target Zone: $17.62 – $21.54 Potential Upside: 78% ROI Time to Expiration: 164 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 30 at 6:05 PM
$MMSI Share Price: $81.27 Contract Selected: Jul 17, 2026 $85 Calls Buy Zone: $9.35 – $11.55 Target Zone: $17.37 – $21.23 Potential Upside: 75% ROI Time to Expiration: 167 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 29 at 2:16 AM
$MMSI RSI: 27.46, MACD: -1.4467 Vol: 4.23, MA20: 85.06, MA50: 85.65 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
ZacksResearch
ZacksResearch Jan. 27 at 6:00 PM
$MMSI looks like a smart add right now — here’s the bull case 👀📈 WRAPSODY reimbursement tailwinds, an expanding high-margin portfolio, and strong cash flow are setting Merit Medical up for growth into 2026, even with macro and forex headwinds in the mix. See why MMSI could be a solid portfolio addition 👉 https://www.zacks.com/stock/news/2823706/heres-why-you-should-add-merit-medical-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2823706-teaser-30507&ADID=SYND_STOCKTWITS_TWEET_2_2823706_TEASER_30507
0 · Reply
ZacksResearch
ZacksResearch Jan. 27 at 5:00 PM
$MMSI poised for growth, but what are the risks? ⚖️ A strong product portfolio and impressive average earnings surprise of 14.1% in the past four quarters bolster optimism for Merit Medical. However, shares have declined 2.3% over the past six months, and macroeconomic headwinds and reimbursement uncertainties remain significant challenges. 📉 See the full bull/bear case on MMSI 👉 https://www.zacks.com/stock/news/2823706/heres-why-you-should-add-merit-medical-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2823706-body-30474&ADID=SYND_STOCKTWITS_TWEET_2_2823706_BODY_30474
0 · Reply
medguy
medguy Jan. 9 at 8:08 PM
Out with small gains $MMSI
0 · Reply
medguy
medguy Jan. 9 at 5:57 PM
Looking for a bounce $MMSI
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 2 at 12:43 PM
$MMSI RSI: 76.15, MACD: 0.7261 Vol: 1.78, MA20: 86.39, MA50: 86.01 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
ESOPExpertV2
ESOPExpertV2 Dec. 25 at 10:59 AM
$MMSI The next leg of valuation movement will likely hinge on how management navigates competing priorities. Operating leverage needs to emerge without sacrificing balance‑sheet resilience. Any disconnect between guidance and results will be magnified by sentiment. This becomes a story about execution quality rather than promises made.
0 · Reply
ZacksResearch
ZacksResearch Dec. 23 at 7:45 PM
$MMSI down 9% YTD — is it poised for a comeback? 📈 Despite recent declines, Merit Medical's strong product portfolio and R&D investment drive optimism. The company saw 7.8% organic constant-currency growth in Q3'25, with cardiovascular momentum taking the lead. See if this Zacks Rank #3 stock is an opportunity 👉 https://www.zacks.com/stock/news/2808197/heres-why-you-should-retain-merit-medical-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2808197-body-26102&ADID=SYND_STOCKTWITS_TWEET_2_2808197_BODY_26102
0 · Reply
ZacksResearch
ZacksResearch Dec. 23 at 6:45 PM
$MMSI is under pressure — but this isn’t a broken story 👀 Despite 2025 share pressure, the company is showing resilience with cardiovascular growth, margin expansion, and growing momentum from WRAPSODY CIE supporting the investment case. See why retaining this stock still makes sense right now 👉 https://www.zacks.com/stock/news/2808197/heres-why-you-should-retain-merit-medical-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2808197-teaser-26101&ADID=SYND_STOCKTWITS_TWEET_2_2808197_TEASER_26101
0 · Reply